- A patient with familial hypercholesterolemia has a defective LDL receptor. Which of the following would be the most direct consequence of this defect on lipoprotein metabolism?
Answer: Accumulation of cholesterol-rich LDL particles in the plasma due to impaired cellular uptake
Defective LDL receptors directly impair the receptor-mediated endocytosis of LDL particles by cells, particularly hepatocytes. This leads to accumulation of cholesterol-rich LDL in the plasma because the particles cannot be efficiently removed from circulation. Choice A is incorrect because VLDL synthesis is not directly affected by LDL receptor defects. Choice C is wrong because lipoprotein lipase acts on VLDL and chylomicrons, not LDL. Choice D is incorrect because reverse cholesterol transport involves HDL, not LDL receptors.
- In a patient with Type III hyperlipoproteinemia (dysbetalipoproteinemia), there is a defect in apolipoprotein E. Which step in lipoprotein metabolism would be most directly impaired?
Answer: Hepatic recognition and uptake of chylomicron remnants and VLDL remnants (IDL)
When you encounter questions about apolipoprotein defects, focus on the specific function of each apoprotein in lipoprotein metabolism. Apolipoprotein E (apoE) serves as a crucial recognition signal for hepatic uptake of remnant lipoproteins.
ApoE acts as a ligand that binds to hepatic receptors (LDL receptor and LDL receptor-related protein) to facilitate the clearance of chylomicron remnants and VLDL remnants (IDL particles) from circulation. In Type III hyperlipoproteinemia, defective apoE cannot properly bind to these receptors, causing remnant particles to accumulate in the bloodstream. This leads to the characteristic "broad beta" pattern on electrophoresis and elevated cholesterol and triglycerides.
Choice A is incorrect because lipoprotein lipase activation depends on apoC-II, not apoE. Patients with apoE defects typically have normal peripheral lipolysis. Choice B describes CETP activity, which transfers cholesteryl esters between lipoproteins but doesn't require apoE for this function. Choice C involves VLDL assembly and secretion from the liver, a process that depends on apoB-100 and microsomal transfer protein, not apoE.
The key study tip for lipoprotein disorders: match each apoprotein to its specific function. ApoB-48/100 for structural integrity, apoC-II for LPL activation, apoC-III for LPL inhibition, and apoE for hepatic uptake of remnants. When you see apoE defects, immediately think "remnant accumulation" because these particles can't be properly cleared by the liver.
- After a person consumes a meal rich in fats, the fatty acids are packaged into triacylglycerols and transported from the intestine. Several hours later, the liver's hepatocytes show an increased uptake of lipid particles derived from this meal. This process is mediated by the uptake of which specific lipoprotein?
Answer: Chylomicron remnants, which are depleted of triacylglycerols but still rich in dietary cholesterol.
Dietary fats are transported from the intestine in chylomicrons. In circulation, lipoprotein lipase removes most of the triacylglycerols for use by peripheral tissues. The resulting particle, smaller and denser, is called a chylomicron remnant. These remnants, which still contain dietary cholesterol, cholesteryl esters, and fat-soluble vitamins, are specifically cleared from the circulation by receptors on hepatocytes.
- During a prolonged fast (e.g., 24 hours), the liver actively synthesizes and secretes VLDL particles. What is the primary metabolic purpose of this process in the fasting state?
Answer: To export fatty acids, mobilized from adipose tissue and synthesized de novo, to tissues like muscle for β-oxidation.
When analyzing VLDL metabolism during fasting, focus on the liver's role as a metabolic hub that redistributes energy substrates to meet the body's needs when glucose is scarce.
During prolonged fasting, your body shifts from glucose to fat as its primary fuel source. The liver becomes central to this metabolic transition by packaging fatty acids into VLDL particles for export. These fatty acids come from two main sources: mobilization from adipose tissue stores (delivered to the liver as free fatty acids) and de novo synthesis within hepatocytes themselves. The liver then assembles these fatty acids into triacylglycerols, packages them with apolipoproteins into VLDL particles, and secretes them into circulation. Muscle and other peripheral tissues can then extract these fatty acids for β-oxidation, generating the ATP needed to sustain cellular function when glucose availability is limited.
Option B is incorrect because during fasting, dietary fatty acid stores would already be depleted after 24 hours—the liver is mobilizing endogenous fat stores, not dietary remnants. Option C misidentifies the primary purpose; while VLDL does carry some cholesterol, its main cargo during fasting is energy-providing fatty acids, not cholesterol for steroidogenesis. Option D contradicts the actual metabolic situation—blood triacylglycerol levels aren't elevated from dietary excess during fasting, and VLDL synthesis actually increases rather than clears circulating lipids.
Remember that VLDL function changes dramatically between fed and fasted states. In fasting, think "energy export system" rather than "lipid storage vehicle."
- The distinct protein compositions of apolipoprotein B-48 and apolipoprotein B-100, which are crucial for the exogenous and endogenous pathways respectively, arise from a single gene. What molecular mechanism accounts for the production of the shorter ApoB-48 exclusively in the intestine?
Answer: Site-specific deamination of a cytosine to a uracil in the mRNA transcript, creating a premature stop codon.
The production of ApoB-48 from the same gene as ApoB-100 is a classic example of tissue-specific mRNA editing. In intestinal enterocytes, an enzyme complex deaminates a specific cytidine nucleotide (C) in the mRNA to a uridine (U). This changes a CAA codon, which codes for glutamine, into a UAA codon, which is a stop codon. This results in the translation of a truncated protein that is approximately 48% of the length of the full ApoB-100 protein synthesized in the liver.
- A research study compares two populations with different genetic variants of PCSK9 (proprotein convertase subtilisin/kexin type 9). Population A has loss-of-function mutations, while Population B has gain-of-function mutations. What would be the expected difference in LDL cholesterol levels between these populations?
Answer: Population A would have lower LDL cholesterol because PCSK9 loss-of-function preserves LDL receptors
When you encounter questions about PCSK9, focus on its role as a regulator of LDL receptor availability. PCSK9 is a protein that binds to LDL receptors on liver cells and promotes their degradation, effectively reducing the cell's ability to remove LDL cholesterol from the bloodstream.
Population A has loss-of-function PCSK9 mutations, meaning their PCSK9 protein works poorly or not at all. Without functional PCSK9 to degrade them, LDL receptors persist on liver cell surfaces much longer. More LDL receptors means more efficient removal of LDL cholesterol from blood, resulting in lower LDL cholesterol levels. This makes answer D correct.
Answer A reverses the logic entirely. While it correctly states that PCSK9 promotes LDL receptor degradation, it incorrectly concludes that Population A (loss-of-function) would have higher LDL cholesterol. Less PCSK9 activity actually preserves more receptors and lowers LDL.
Answer B misunderstands PCSK9's mechanism. PCSK9 doesn't directly affect cholesterol synthesis - it regulates receptor-mediated cholesterol clearance. Gain-of-function mutations would actually increase LDL cholesterol by destroying more receptors.
Answer C is factually wrong. PCSK9 primarily affects LDL metabolism, not HDL metabolism, and the populations would definitely show differences in LDL levels.
Remember this pathway: PCSK9 ↑ → LDL receptors ↓ → LDL cholesterol ↑. Loss-of-function mutations break this chain early, while gain-of-function mutations amplify it. PCSK9 inhibitors are now major cholesterol medications based on this exact mechanism.
- A researcher is studying the effects of a novel compound on lipid metabolism. The compound specifically inhibits CETP (cholesteryl ester transfer protein). What would be the expected outcome on lipoprotein profiles after treatment with this compound?
Answer: Increased HDL cholesterol levels and decreased LDL cholesterol levels due to blocked lipid transfer
When you encounter questions about lipid metabolism proteins like CETP, focus on understanding what each protein does and how inhibiting it affects the normal flow of lipids between lipoproteins.
CETP (cholesteryl ester transfer protein) facilitates the transfer of cholesteryl esters from HDL to apoB-containing lipoproteins (like LDL and VLDL) in exchange for triglycerides. Think of CETP as a molecular shuttle that moves cholesteryl esters from "good" HDL particles to "bad" LDL particles. When you block this shuttle with an inhibitor, cholesteryl esters remain trapped in HDL particles, making them larger and more cholesterol-rich, while LDL particles receive fewer cholesteryl esters and become smaller and less atherogenic.
Choice A correctly describes this outcome: HDL cholesterol levels increase because cholesteryl esters can't leave HDL particles, and LDL cholesterol levels decrease because fewer cholesteryl esters are transferred to LDL.
Choice B is backwards—HDL cholesterol would increase, not decrease, when transfer is blocked. Choice C incorrectly suggests CETP works intracellularly, when it actually functions in plasma to transfer lipids between different lipoprotein particles. Choice D confuses CETP's role with other proteins involved in chylomicron metabolism; CETP doesn't directly affect chylomicron clearance.
Remember that CETP inhibitors have been developed as potential cardiovascular drugs precisely because blocking cholesteryl ester transfer raises HDL and can lower LDL—though clinical outcomes have been mixed, demonstrating that higher HDL doesn't always translate to better cardiovascular protection.
- A researcher is investigating the endogenous lipid transport pathway. A drug is administered that selectively inhibits hepatic lipase activity without affecting lipoprotein lipase. Which of the following is the most probable consequence of this inhibition?
Answer: An increase in the plasma concentration of intermediate-density lipoprotein (IDL).
In the endogenous pathway, VLDL is converted to IDL by lipoprotein lipase (LPL). Hepatic lipase (HL) is then involved in the final conversion of IDL to LDL by hydrolyzing remaining triacylglycerols and phospholipids. If HL is inhibited, this final conversion step is blocked, leading to an accumulation of the precursor, IDL, in the circulation.
- A patient with familial hypercholesterolemia has a mutation in the APOB gene. This mutation affects the structure of apolipoprotein B-100, specifically preventing its effective binding to the LDL receptor, but does not interfere with its role in VLDL assembly and secretion from the liver. Which metabolic profile is most consistent with this specific defect?
Answer: Normal secretion of VLDL from the liver, but elevated plasma concentrations of LDL due to impaired clearance.
ApoB-100 has two key roles: structural integrity for VLDL/IDL/LDL and acting as the ligand for the LDL receptor. The question states that VLDL assembly/secretion is normal, so the liver will produce and secrete VLDL at a typical rate. VLDL will be converted to IDL and then to LDL in circulation. However, because the ApoB-100 on the resulting LDL particle cannot bind to the LDL receptor, clearance of LDL from the blood is severely impaired, leading to high plasma LDL levels.
- During fasting, the liver increases VLDL production. If a patient has a genetic deficiency in microsomal triglyceride transfer protein (MTP), what would be the expected effect on VLDL secretion during prolonged fasting?
Answer: Severely impaired VLDL secretion despite increased hepatic triglyceride synthesis
MTP is essential for the assembly of apoB-containing lipoproteins in both the liver (VLDL) and intestine (chylomicrons). It transfers lipids to apoB during lipoprotein assembly. Without functional MTP, the liver cannot properly assemble and secrete VLDL particles, even though triglyceride synthesis may be increased during fasting. This leads to hepatic steatosis. Choice A is incorrect because MTP functions in both liver and intestine. Choice B is wrong because there are no adequate alternative mechanisms. Choice D reverses MTP's actual function.
- The development of atherosclerosis is strongly linked to the formation of macrophage-derived foam cells in the arterial wall. This pathological process is primarily initiated by the unregulated uptake of which modified lipoprotein via which class of receptor?
Answer: Oxidized LDL particles via scavenger receptors, which are not subject to feedback inhibition by cholesterol.
A key event in atherogenesis is the modification of LDL, particularly through oxidation, in the subendothelial space. Macrophages do not readily take up native LDL. However, they express scavenger receptors (e.g., SR-A, CD36) that recognize and internalize modified or oxidized LDL. Crucially, unlike the LDL receptor, scavenger receptors are not downregulated by high intracellular cholesterol. This leads to uncontrolled uptake of oxidized LDL, massive cholesterol accumulation, and the transformation of macrophages into lipid-laden foam cells.
- In an individual with a genetic deficiency of lecithin-cholesterol acyltransferase (LCAT), extremely low levels of circulating HDL are observed. What is the primary biochemical mechanism responsible for this finding?
Answer: Cholesterol cannot be esterified within nascent HDL, preventing the formation of a nonpolar core and maturation into spherical HDL.
LCAT, activated by ApoA-I, is the enzyme that esterifies free cholesterol collected by nascent HDL from peripheral tissues. This esterification traps the hydrophobic cholesteryl ester in the core of the lipoprotein, allowing more free cholesterol to be taken up. This process is essential for the maturation of the small, nascent HDL discs into larger, spherical HDL particles (HDL3 and HDL2). Without LCAT, this maturation fails, and the unstable nascent particles are rapidly cleared from circulation, resulting in very low HDL levels.
- During the postprandial state, chylomicrons undergo lipolysis by lipoprotein lipase at capillary beds. What happens to the apolipoprotein composition as chylomicrons are converted to chylomicron remnants?
Answer: ApoC-II and apoC-III are transferred to HDL while apoB-48 and apoE remain on the remnant
As chylomicrons undergo lipolysis, the C apolipoproteins (apoC-II and apoC-III) are transferred to HDL particles, while the structural apolipoprotein apoB-48 remains on the particle. ApoE also remains on the remnant and is crucial for hepatic uptake via the LDL receptor-related protein. Choice A is incorrect because apoB-48 is the structural protein and cannot be transferred. Choice C is wrong because lipoprotein lipase hydrolyzes triglycerides, not proteins. Choice D is incorrect because apoE is acquired from HDL during chylomicron maturation, not synthesized de novo on the particle.
- A patient with a rare genetic disorder is found to have a complete loss-of-function mutation in the gene encoding apolipoprotein C-II (ApoC-II). In the fed state, which of the following laboratory findings would be the most direct and prominent consequence of this defect?
Answer: Marked elevation of triacylglycerol-rich lipoproteins, specifically chylomicrons and VLDL, in the plasma.
ApoC-II is a crucial activator of lipoprotein lipase (LPL), the enzyme responsible for hydrolyzing triacylglycerols in both chylomicrons (from the diet) and VLDL (from the liver). Without functional ApoC-II, LPL activity is severely diminished, preventing the breakdown of these particles. This leads to their accumulation in the plasma, causing severe hypertriglyceridemia, which is especially prominent in the fed state when chylomicrons are present.
- In abetalipoproteinemia, patients cannot synthesize apolipoprotein B. Which of the following would be the most direct metabolic consequence of this genetic defect?
Answer: Inability to transport dietary lipids from intestine and endogenous lipids from liver
ApoB is the essential structural protein for both chylomicrons (apoB-48) and VLDL/LDL (apoB-100). Without apoB, patients cannot assemble or secrete these lipoproteins, preventing transport of dietary fats from the intestine and endogenous lipids from the liver. Choice B is incorrect because HDL formation depends on apoA-I, not apoB. Choice C is wrong because the problem is inability to transport lipids out of tissues, not into them. Choice D is incorrect because lipoprotein lipase would have no substrate to act upon without apoB-containing lipoproteins.
- Apolipoprotein E (ApoE) is critical for lipid homeostasis. A loss-of-function mutation in ApoE would most directly impair which of the following lipid transport processes?
Answer: The hepatic clearance of chylomicron remnants via the remnant receptor and the clearance of IDL particles.
ApoE serves as a high-affinity ligand for receptors in the liver that are responsible for clearing remnant particles from circulation. Specifically, it mediates the binding and endocytosis of chylomicron remnants (after they have been acted upon by LPL) and intermediate-density lipoproteins (IDL), the remnants of VLDL catabolism. A lack of functional ApoE would therefore impair the clearance of both types of remnants, leading to their accumulation.
- A new class of drugs that inhibit cholesteryl ester transfer protein (CETP) has been developed. Based on the known function of CETP, what would be the expected primary effect on the plasma lipoprotein profile in a patient treated with an effective dose of one of these drugs?
Answer: An increase in HDL cholesterol and a decrease in LDL cholesterol levels.
When you encounter questions about lipid transport proteins, focus on understanding the specific role each protein plays in moving lipids between different lipoproteins.
CETP facilitates the transfer of cholesteryl esters from HDL to apoB-containing lipoproteins (VLDL and LDL) in exchange for triacylglycerols. This process normally reduces HDL cholesterol levels while increasing cholesterol content in VLDL and LDL particles. When CETP is inhibited, this transfer is blocked.
Without functional CETP, cholesteryl esters remain in HDL particles, leading to increased HDL cholesterol levels. Simultaneously, less cholesterol is transferred to VLDL and LDL, resulting in decreased LDL cholesterol levels. This makes option A correct.
Option B is wrong because CETP inhibition would actually increase HDL cholesterol (not decrease it), and while VLDL composition might change, total VLDL levels aren't the primary effect. Option C incorrectly focuses on chylomicrons, which are primarily involved in dietary fat transport and aren't the main target of CETP activity. Option D suggests increased VLDL secretion, but CETP inhibition affects lipid transfer between existing lipoproteins rather than stimulating new lipoprotein synthesis or secretion from the liver.
For biochemistry exams, remember that transport proteins like CETP act as "shuttles" moving specific components between lipoproteins. When these shuttles are blocked, think about where the transported material gets "stuck" - this will help you predict the resulting changes in lipoprotein composition.
- Intracellular lipid droplets and plasma lipoproteins like chylomicrons both consist of a neutral lipid core. A key structural feature that distinguishes a chylomicron from an intracellular lipid droplet is the presence of:
Answer: specific apolipoproteins embedded in its surface monolayer, which are required for secretion and metabolism.
When you encounter questions comparing different lipid-containing structures, focus on their key structural and functional differences, particularly what enables their specific biological roles.
Chylomicrons and intracellular lipid droplets both store neutral lipids (primarily triacylglycerols) in their cores, but they serve very different functions. Chylomicrons must travel through the bloodstream to deliver dietary lipids to tissues, while lipid droplets remain within cells for local storage. This functional difference requires distinct structural features.
The defining characteristic of chylomicrons is their surface apolipoproteins - specialized proteins like apoB-48, apoC-II, and apoE that are embedded in their phospholipid monolayer surface. These apolipoproteins are essential for chylomicron assembly, secretion from intestinal cells, recognition by lipoprotein lipase for triglyceride hydrolysis, and uptake by target tissues. Lipid droplets lack these apolipoproteins entirely.
Choice B is incorrect because both structures contain predominantly triacylglycerols, not cholesteryl esters as their major component. Choice C misrepresents the membrane structure - both have phospholipid monolayers surrounding their neutral lipid cores, not bilayers. Choice D oversimplifies lipid origins; while chylomicrons do transport dietary lipids, lipid droplets can store both dietary-derived and endogenously synthesized lipids.
For biochemistry exams, remember that lipoproteins are distinguished by their apolipoprotein composition, which determines their metabolic fate. The presence and type of apolipoproteins is what allows lipoproteins to function in lipid transport, unlike simple intracellular storage structures.
- Receptor-mediated endocytosis of LDL particles is a critical process for cellular cholesterol homeostasis. An increase in free intracellular cholesterol resulting from this process triggers a feedback mechanism that includes:
Answer: allosteric inhibition of HMG-CoA reductase and decreased transcription of the gene for the LDL receptor.
High intracellular cholesterol levels initiate a coordinated response to prevent further accumulation. This involves: 1) Decreasing de novo cholesterol synthesis by inhibiting HMG-CoA reductase (the rate-limiting enzyme) and reducing its gene transcription. 2) Reducing cholesterol uptake from the circulation by decreasing the synthesis of new LDL receptors. 3) Increasing cholesterol storage by activating acyl-CoA:cholesterol acyltransferase (ACAT) to esterify it. Option B correctly identifies the first two key negative feedback events.
- When comparing the major classes of lipoproteins from a blood sample drawn after a 12-hour fast, which class would be expected to have the highest percentage of protein relative to its total mass?
Answer: High-density lipoproteins (HDL), which are involved in reverse cholesterol transport.
Lipoprotein density is inversely related to lipid content and directly related to protein content. HDL is the smallest and most dense of the lipoproteins, containing the highest percentage of protein (around 40-55%) and the lowest percentage of lipid. In contrast, chylomicrons are the least dense and are almost entirely lipid (1-2% protein). VLDL and LDL have intermediate compositions, with VLDL being richer in lipid than LDL. After a 12-hour fast, chylomicrons from the diet would be absent or at very low levels.
